Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies.

about

Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies.

Item

http://www.wikidata.org/entity/Q53837722

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Single-agent GvHD prophylaxis ...... th hematological malignancies.

@en

Single-agent GvHD prophylaxis ...... th hematological malignancies.

@nl

type

Item

label

Single-agent GvHD prophylaxis ...... th hematological malignancies.

@en

Single-agent GvHD prophylaxis ...... th hematological malignancies.

@nl

prefLabel

Single-agent GvHD prophylaxis ...... th hematological malignancies.

@en

Single-agent GvHD prophylaxis ...... th hematological malignancies.

@nl

P1476

Single-agent GvHD prophylaxis ...... th hematological malignancies.

@en

P2093

A Esquirol

http://www.w3.org/2001/XMLSchema#string

C Ferra

http://www.w3.org/2001/XMLSchema#string

I Garcia Cadenas

http://www.w3.org/2001/XMLSchema#string

I Vilades

http://www.w3.org/2001/XMLSchema#string

J Sierra

http://www.w3.org/2001/XMLSchema#string

M J Pascual

http://www.w3.org/2001/XMLSchema#string

M Ortiz

http://www.w3.org/2001/XMLSchema#string

R Martino

http://www.w3.org/2001/XMLSchema#string

S Brunet

http://www.w3.org/2001/XMLSchema#string

P2860

Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow-Review of Published Literature

Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation

Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

Hematopoietic stem-cell transplantation.

How I assess comorbidities before hematopoietic cell transplantation

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

P2888

bmt.2017.111

P304

1273-1279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2017.111

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

José Luis Piñana

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28604667

http://www.w3.org/2001/XMLSchema#string